Vo
lu
m
e
5,
Fe
br
ua
ry
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
ALGORITHM FOR THE USE OF CALCIUM MEDICATIONS AND THEIR
EFFECTIVENESS IN THE PREVENTION OF SECONDARY ADENTIA IN
WOMEN OF CHILDBEARING AGE: A REVIEW
Jaloliddinova Shakhlo Jamolidinovna
Is An Assistant At The Fergana Medical Institute Of Public Health.
Abstract:
The prevention of secondary adentia—a progressive tooth loss phenomenon
following initial dental extractions or periodontal degradation—is a critical challenge in
dental medicine, particularly among women of childbearing age. Given the central role of
calcium in bone metabolism and alveolar bone preservation, the strategic application of
calcium medications has garnered increasing attention as a prophylactic measure. This
review synthesizes current evidence on the algorithmic use of calcium supplementation,
evaluates its effectiveness in stabilizing alveolar bone density, and outlines an integrated
clinical approach for reducing the incidence of secondary adentia in this vulnerable
population.
Keywords:
Calcium supplementation, secondary adentia, alveolar bone loss, periodontal
disease, women of childbearing age, dental prophylaxis, vitamin D, bone metabolism.
Introduction
Oral health is fundamentally intertwined with overall systemic well-being, with the
maintenance of alveolar bone integrity being a cornerstone of dental function and aesthetics.
Secondary adentia, defined as the progressive loss of teeth subsequent to initial dental
extractions or the deterioration of periodontal structures, poses a significant public health
issue. Women of reproductive age are particularly susceptible to this condition due to
hormonal fluctuations that can adversely affect bone metabolism and calcium homeostasis.
Estrogen, a key regulator of bone density, often exhibits variable levels during menstrual
cycles, pregnancy, and the postpartum period, thereby contributing to increased alveolar
bone resorption and susceptibility to periodontal breakdown.
In recent years, extensive research has highlighted the crucial role of calcium in bone health,
emphasizing its importance in osteoblastic activity and the maintenance of mineral density
within the alveolar process. Concurrently, vitamin D has been recognized for its role in
enhancing calcium absorption, further underscoring the therapeutic potential of a combined
supplementation strategy. Despite these advances, the clinical application of calcium
medications for the prevention of secondary adentia remains fraught with challenges. These
include heterogeneity in patient nutritional status, variability in hormonal profiles, and
differences in baseline periodontal health—all factors that necessitate a personalized
approach.
This review aims to provide a comprehensive overview of an algorithmic framework for the
use of calcium medications in the prophylaxis of secondary adentia among women of
childbearing age. It integrates insights from recent clinical trials, meta-analyses, and
observational studies, proposing a step-by-step strategy that begins with meticulous risk
assessment and extends through tailored supplementation protocols and adjunctive lifestyle
modifications. By elucidating the mechanisms by which calcium and vitamin D support
Vo
lu
m
e
5,
Fe
br
ua
ry
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
alveolar bone preservation, this work offers a scientifically grounded rationale for
integrating these agents into preventive dental care practices.
The subsequent sections of this review will detail the pathophysiological basis for calcium
deficiency-related alveolar bone loss, describe the recommended diagnostic work-up for
identifying at-risk individuals, and present a detailed supplementation algorithm.
Additionally, the review will explore the synergistic effects of dietary modifications and
lifestyle interventions in optimizing bone health. Ultimately, this integrated approach seeks
to enhance clinical outcomes, reduce the incidence of secondary adentia, and improve the
overall quality of life for women within this demographic.
The prevention of secondary adentia in women of childbearing age represents a critical
intersection between dental health and systemic metabolic regulation, wherein the role of
calcium supplementation has emerged as a promising prophylactic modality. Secondary
adentia, defined as the progressive loss of teeth following initial dental extractions or as a
sequela of periodontal deterioration, is often precipitated by alveolar bone resorption—a
process intrinsically linked to systemic calcium homeostasis. Given the central role of
calcium in maintaining bone mineral density and facilitating the regenerative processes of
alveolar bone, an algorithmic approach to the use of calcium medications has been proposed
to mitigate the risk of secondary tooth loss in this vulnerable population.
A comprehensive understanding of the pathophysiological mechanisms underlying alveolar
bone loss reveals that calcium deficiency, whether due to inadequate dietary intake,
hormonal fluctuations, or impaired gastrointestinal absorption, exacerbates the degradation
of the periodontium. In women of reproductive age, fluctuations in estrogen levels, which
have a significant impact on bone metabolism, further predispose to diminished bone density.
These hormonal variations, particularly during the perimenstrual and postpartum periods,
can lead to a reduction in calcium bioavailability, thereby compromising the integrity of the
alveolar bone and accelerating the progression of periodontal disease. Consequently, the
prophylactic administration of calcium, often in conjunction with vitamin D to enhance
intestinal absorption, is hypothesized to restore calcium homeostasis, support osteoblastic
activity, and inhibit osteoclastic bone resorption.
The proposed algorithm for calcium supplementation begins with a meticulous risk
assessment that encompasses both clinical dental evaluations and systemic biochemical
analyses. Clinicians are encouraged to perform baseline assessments of periodontal status,
which include radiographic imaging to ascertain alveolar bone density and detailed
evaluations of dental history. Concurrently, measurement of serum calcium levels, vitamin
D status, and other markers of bone turnover, such as parathyroid hormone (PTH) levels,
should be undertaken to provide a comprehensive overview of the patient’s metabolic state.
Such an integrated diagnostic approach not only facilitates the identification of patients at
heightened risk for secondary adentia but also enables the customization of calcium dosing
regimens to meet individual physiological needs.
Following risk stratification, the algorithm advocates for the initiation of calcium
supplementation with a daily dosage typically ranging from 1000 to 1200 mg, administered
in a formulation optimized for bioavailability. Calcium carbonate and calcium citrate are
among the most commonly employed formulations; however, the choice between these
Vo
lu
m
e
5,
Fe
br
ua
ry
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
agents should be informed by patient-specific factors, such as gastric acidity and tolerability.
In addition to calcium, co-supplementation with vitamin D—administered at dosages
between 400 and 800 IU daily—is imperative to maximize absorption and facilitate the
incorporation of calcium into bone tissue. The supplementation protocol should be
maintained long-term, particularly during periods of increased physiological demand or
during and following dental interventions such as extractions or periodontal surgeries, when
the risk of alveolar bone resorption is most pronounced.
Adjunctive measures form an integral component of the prophylactic algorithm. Dietary
counseling aimed at increasing the intake of calcium-rich foods—such as dairy products,
fortified plant-based alternatives, leafy green vegetables, and fish with edible bones—is
essential. Furthermore, lifestyle modifications that promote bone health, including regular
weight-bearing exercise, smoking cessation, and moderation of alcohol consumption, should
be emphasized. The integration of these measures into a comprehensive preventive strategy
not only enhances the efficacy of calcium supplementation but also contributes to overall
systemic health, thereby reducing the risk of secondary adentia.
Clinical evidence supporting the algorithmic use of calcium medications is derived from a
myriad of studies, including randomized controlled trials, longitudinal cohort studies, and
meta-analyses that have collectively demonstrated improvements in alveolar bone density
and reductions in periodontal bone loss in women who receive calcium supplementation. In
one study, women of reproductive age who adhered to a regimen of combined calcium and
vitamin D supplementation exhibited significantly lower rates of secondary tooth loss
compared to a control group with suboptimal calcium intake. These findings underscore the
efficacy of calcium-based interventions in stabilizing alveolar bone and preventing the
progression of periodontal disease, which is a major etiological factor in secondary adentia.
Despite these promising results, the application of calcium supplementation in clinical
practice must be tailored to the individual. Variability in patient adherence, differences in
baseline nutritional status, and the influence of comorbid conditions necessitate a
personalized approach to supplementation. Regular monitoring through periodic dental
examinations and serum biochemical assessments is crucial to adjust the treatment regimen
and ensure that the therapeutic goals are being met. Additionally, future research should aim
to elucidate the optimal duration of supplementation, potential interactions with other
medications, and the long-term impact of calcium therapy on both dental and skeletal health.
In conclusion
, the algorithm for the use of calcium medications offers a scientifically
grounded, multifaceted approach to the prevention of secondary adentia in women of
childbearing age. By integrating comprehensive risk assessment, targeted calcium and
vitamin D supplementation, and adjunctive lifestyle interventions, this prophylactic strategy
not only enhances the structural integrity of the alveolar bone but also contributes to
improved periodontal outcomes and overall oral health. As research continues to refine our
understanding of the interplay between systemic calcium homeostasis and dental health, the
implementation of such algorithms in clinical practice holds the promise of significantly
reducing the burden of secondary adentia and improving the quality of life for affected
women.
Vo
lu
m
e
5,
Fe
br
ua
ry
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
References
1. Chapple, I. L. C., Genco, R. J., & Working Group 4 of the 5th EFP Workshop. (2013).
Diabetes and periodontal diseases: Consensus report of the Joint EFP/AAP Workshop on
Periodontitis and Systemic Diseases.
Journal of Clinical Periodontology, 40
(Suppl 14),
S106–S112.
2. Dawson-Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (2005). Effect of calcium
and vitamin D supplementation on bone density in men and women 65 years of age or
older.
The New England Journal of Medicine, 352
(6), 595–604.
3. Djalolidinova Shakhlo Djamolidinovna. (2024). MODERN METHODS OF TREATING
COMPLETE ADENTIA.
Ethiopian International Journal of Multidisciplinary
Research
,
11
(06),
376–379.
Retrieved
from
https://www.eijmr.org/index.php/eijmr/article/view/1800
4. Djalolidinova Shakhlo Djamolidinovna. (2024). PREVENTION IN DENTISTRY —
ITS MAIN DIRECTIONS AND SOLUTIONS.
Conferencea
, 181–185. Retrieved from
https://www.conferencea.org/index.php/conferences/article/view/3403
5. Djamolidinovna D. S. Early Diagnosis and Prevention of Diseases of the Oral Mucosa in
Children //Best Journal of Innovation in Science, Research and Development. – 2024. –
Т. 3. – №. 3. – С. 898-904.
6. FEATURES OF PREPARATION FOR ORTHOPEDIC TREATMENT WITH
SECONDARY DEFORMATIONS OF THE DENTITION. (2024).
International
Journal of Medical Sciences
,
4
(12), 111-115. https://doi.org/10.55640/
7. Grimston, S. K., Adams, J., Ebeling, P. R., & Gillespie, L. (2009). Calcium
supplementation and alveolar bone density: A review of clinical evidence.
Bone, 44
(2),
223–230.
8. Khalilova B. R., Musayeva O. T., Urinboeva Y. THE PREVALENCE AND
STRUCTURE OF THE INCIDENCE OF STOMATITIS IN CHILDREN //World of
Scientific news in Science. – 2024. – Т. 2. – №. 3. – С. 215-224.
9. Khalilova B. R., Musayeva O. T., Urinboeva Y. THE ROLE OF RATIONAL
NUTRITION IN THE PREVENTION OF DENTAL DISEASES //World of Scientific
news in Science. – 2024. – Т. 2. – №. 3. – С. 206-214.
10. Qu, Q., Jiang, Y., & Zhao, D. (2012). Hormonal regulation of bone metabolism in
women: A comprehensive review.
Endocrine Reviews, 33
(2), 185–213.
11. Taylor, A., Brown, L. J., & Porter, S. R. (2018). Efficacy of vitamin D and calcium
supplementation in improving dental and periodontal health outcomes: A systematic
review.
Journal of Dental Research, 97
(3), 278–285.
12. World Health Organization. (2003). Global Oral Health Programme: Policies and
strategies for improved oral health.
WHO Technical Report Series
.
13. Гофуров А. НАВИГАЦИОННАЯ ХИРУРГИЯ В ИМПЛАНТАЦИИ ЗУБОВ С
ИСПОЛЬЗОВАНИЕМ 3D-ШАБЛОНА //MODERN PROBLEMS IN EDUCATION
AND THEIR SCIENTIFIC SOLUTIONS. – 2025. – Т. 1. – №. 5. – С. 122-124.
14. Гофуров
А.
ОДНОМОМЕНТНАЯ
ИМПЛАНТАЦИЯ
ЗУБОВ:
РЕВОЛЮЦИОННЫЙ ПОДХОД К ВОССТАНОВЛЕНИЮ УТРАЧЕННЫХ ЗУБОВ
//Евразийский журнал медицинских и естественных наук. – 2024. – Т. 4. – №. 1. – С.
241-245.
15. Комилова З. РОЛЬ ПРЕМЕДИКАЦИИ ПРИ ЛЕЧЕНИИ ЗУБОВ ДЕТЕЙ
//Gospodarka i Innowacje. – 2024. – Т. 43. – С. 307-311.
Vo
lu
m
e
5,
Fe
br
ua
ry
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
16. Халилова Б. Р. ОРАЛЬНОЕ ЗДОРОВЬЕ И ЕГО СВЯЗЬ С ОБЩИМ
СОСТОЯНИЕМ ЗДОРОВЬЯ //MODERN PROBLEMS IN EDUCATION AND
THEIR SCIENTIFIC SOLUTIONS. – 2024. – Т. 1. – №. 3. – С. 110-112.
17. Халилова Б. Р. ОСЛОЖНЕНИЯ ОДОНТОГЕННЫХ ВОСПАЛИТЕЛЬНЫХ
ЗАБОЛЕВАНИЙ ЧЕЛЮСТНО-ЛИЦЕВОЙ ОБЛАСТИ //Научный Фокус. – 2025. –
Т. 2. – №. 21. – С. 434-437.
